Cancer

Focusing specifically on cancer genes, using both monogenic and polygenic risk panels as part of a whole genome test provides powerful, personalised insights into your cancer risk profile

All Genetic testing packages come with Genetic Counseling or GP service

Monogenic Cancer Risk Panels

These panels look for rare, high-impact mutations in single genes (monogenic), such as BRCA1/2 (breast/ovarian cancer), TP53 (Li-Fraumeni syndrome), MLH1/MSH2 (Lynch syndrome/colorectal cancer), and others.

Significant risk elevation
Identifying a pathogenic mutation often means your lifetime risk for certain cancers is substantially higher than average.
Actionable results
If you carry such a mutation, you may qualify for enhanced screening (e.g., earlier/more frequent mammograms, colonoscopies), preventive surgeries, or targeted therapies.
Family impact
Relatives can be offered testing to clarify their own risk and guide preventive care.

Polygenic Cancer Risk Panels

What they are: These panels assess hundreds or thousands of common genetic variants (SNPs) across your genome. Individually, these variants have a small effect, but when combined into a polygenic risk score (PRS), they can meaningfully stratify your overall genetic risk for cancers like breast, prostate, or colorectal cancer.

Refined risk prediction:
PRS can help place you in a low, average, or high-risk category even if you don’t carry a high-impact monogenic mutation.
Personalized screening
Your PRS can guide decisions on when to start screening and how often, even in the absence of a family history or known monogenic mutations.
Complementary information:
Polygenic risk helps fill in the gaps for the majority of people who do not have monogenic mutations but may still have elevated risk due to the combined effect of many common variants

Why Combine Both?

Comprehensive risk assessment:
Most cancer risk is not explained by single genes alone. Combining monogenic and polygenic panels gives a much more complete picture.

Tailored prevention strategies:
If you have moderate monogenic risk but a high polygenic score, your overall risk could be substantially higher—and your care plan can be adjusted accordingly.

Population-wide relevance:
While monogenic mutations are rare, polygenic risk impacts a much larger segment of the population.

Early identification of at-risk individuals

More personalized cancer screening and prevention

Ability to inform and protect family members

Empowerment to make proactive health decisions

  • Counselling

    Counselling

    £150.00
    £150.00
  • Preventis 17 Gene BRCA/Lynch

    Preventis 17 Gene BRCA/Lynch

    £599.00
    £599.00
  • Preventis Cancer Risk Panel

    Preventis Cancer Risk Panel

    £799.00
    £799.00
  • Preventis MyHealthscore

    Preventis MyHealthscore

    £499.00
    £499.00